Highlights from the 2026 ATS Conference
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Highlights from the 2026 ATS Conference
-
Narrated by:
-
By:
Host Daniel Culver, DO, is joined by Cleveland Clinic pulmonologists Rachel Scheraga, MD, and Vickram Tejwani, MD, for a recap of the 2026 American Thoracic Society Conference (ATS). They discuss key scientific and clinical highlights, including support for early-career investigators, ATS NOW, advances in lung microenvironment research, emerging airway disease therapies targeting IL-33, and promising pulmonary fibrosis data. The conversation also explores how collaboration, technology, and team-based science are reshaping respiratory research and what the future of major medical meetings may look like.
adbl_web_anon_alc_button_suppression_t1
No reviews yet